Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chewy Inc (CHWY) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Chewy Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Chewy Inc trades at $22.57 (market cap $9.20B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 8.9× Chewy Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Chewy Inc pays none. Which is the better fit depends on your goals.

CHWYREGN
Market Cap
$9.20B$82.06B
Sector
Consumer CyclicalHealth
52-Week High
$42.33$812.27
52-Week Low
$17.51$555.51
Enterprise Value
$9.16B$76.77B
Dividend Yield
0.47%

Returns comparison

Trailing returns across standard periods

About Chewy Inc

Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.

Read more on CHWY

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN